164 related articles for article (PubMed ID: 19076368)
1. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
[TBL] [Abstract][Full Text] [Related]
2. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
3. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.
Spitsin S; Stevens KE; Douglas SD
J Neurol Sci; 2013 Nov; 334(1-2):18-23. PubMed ID: 23916293
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals.
Douglas SD; Lynch KG; Lai JP
J Neurol Sci; 2008 Sep; 272(1-2):174-7. PubMed ID: 18572194
[TBL] [Abstract][Full Text] [Related]
5. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
Lai JP; Lai S; Tuluc F; Tansky MF; Kilpatrick LE; Leeman SE; Douglas SD
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12605-10. PubMed ID: 18713853
[TBL] [Abstract][Full Text] [Related]
6. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.
Lai JP; Ho WZ; Kilpatrick LE; Wang X; Tuluc F; Korchak HM; Douglas SD
Proc Natl Acad Sci U S A; 2006 May; 103(20):7771-6. PubMed ID: 16675550
[TBL] [Abstract][Full Text] [Related]
7. Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.
Spitsin S; Tuluc F; Meshki J; Ping Lai J; Tustin Iii R; Douglas SD
Neuroimmunomodulation; 2013; 20(5):247-55. PubMed ID: 23921645
[TBL] [Abstract][Full Text] [Related]
8. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
9. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.
Lai JP; Ho WZ; Zhan GX; Yi Y; Collman RG; Douglas SD
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3970-5. PubMed ID: 11274418
[TBL] [Abstract][Full Text] [Related]
10. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
11. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
12. Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.
Lai JP; Cnaan A; Zhao H; Douglas SD
J Neurosci Methods; 2008 Feb; 168(1):127-33. PubMed ID: 18035424
[TBL] [Abstract][Full Text] [Related]
13. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
[TBL] [Abstract][Full Text] [Related]
14. Neurokinin 1 receptor isoforms and the control of innate immunity.
Tuluc F; Lai JP; Kilpatrick LE; Evans DL; Douglas SD
Trends Immunol; 2009 Jun; 30(6):271-6. PubMed ID: 19427266
[TBL] [Abstract][Full Text] [Related]
15. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
Koh YH; Moochhala S; Bhatia M
J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
[TBL] [Abstract][Full Text] [Related]
16. A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes.
Lai JP; Ho WZ; Yang JH; Wang X; Song L; Douglas SD
J Neuroimmunol; 2002 Jul; 128(1-2):101-8. PubMed ID: 12098517
[TBL] [Abstract][Full Text] [Related]
17. Role of neurogenic substance P in overexpression of alveolar macrophages' neurokinin 1 receptor in mice exposed to cigarette smoke.
Xu J; Xu F
Exp Lung Res; 2010 May; 36(4):243-54. PubMed ID: 20426532
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.
Manak MM; Moshkoff DA; Nguyen LT; Meshki J; Tebas P; Tuluc F; Douglas SD
AIDS; 2010 Nov; 24(18):2789-96. PubMed ID: 20975512
[TBL] [Abstract][Full Text] [Related]
19. Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor.
McConalogue K; Déry O; Lovett M; Wong H; Walsh JH; Grady EF; Bunnett NW
J Biol Chem; 1999 Jun; 274(23):16257-68. PubMed ID: 10347182
[TBL] [Abstract][Full Text] [Related]
20. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L
Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
